Modeling the Effects of Vocal Cord Atrophy on Airflow and Voice Quality in Elderly Individuals

Withdrawn before enrolling · Not applicable

Conditions studied: Vocal Cord Atrophy

In brief

1. The purpose of this study is to develop a validated computational model for assessing normative change in these patterns in patients with vocal cord atrophy before and after voice therapy. 2. This is a prospective study comparing two cohorts - patients with vocal cord atrophy(VCA) (G1) and healthy controls (G2). Subjects with VCA will receive a cone beam computed tomography (CBCT) scan with the standard laryngeal protocol before and after voice therapy. Healthy controls will also receive one cone beam computed tomography (CBCT) scan. Subjects with VCA (G1) will undergo post-therapy scans approximately 4 weeks after completion of voice therapy treatment. Enrolled subjects will also undergo a video stroboscopy and acoustic/aerodynamic testing. Subjects in G1 typically have these procedures performed before and after voice therapy as standard of care. Participants in G2 (healthy controls) will have the video stroboscopy and acoustic/aerodynamic testing just once since they would not otherwise be scheduled to undergo voice therapy. Potential subjects will be between 65 and 80 years of age will be considered for the study if they qualify based on inclusion criteria. Potential subjects will undergo are pre-screening process involving an initial telephone screening. 3. Raw data (measured and calculated) derived from this pilot study will be reported, and no statistical analysis will be performed. Data from specific aim 1 (G2) and specific aim 2 (G1) will be compared using graphical representations such as bar and dot plots. There is a potential for the loss of confidentiality; however, every reasonable effort will be made to limit breaches of privacy and confidentiality. Subjects may directly benefit from this study. In addition, data and conclusions derived from this study may help future patients regarding the effects of vocal therapy on vocal cord atrophy (VCA). The investigators will recruit up to 12 subjects to account for screen failures. Once 8 eligible subjects are enrolled (4 per group), then enrollment will end.

Key facts

Study ID: NCT03458104
Run by: Duke University
People needed: 0
Starts: 2018-03-28
Expected to finish: 2020-09-01
Last updated by the study team: 2020-04-07

Who can join

Age: 65 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Between 65 and 80 years of age
Voice Handicap Index (VHI) questionnaire score of less than 10.
Little or no dysphonia as assessed by a speech language pathologist from the Duke Voice Care Center
No contraindications to have a CBCT scan (as assessed per standard clinical practice)

You may not qualify if…

Inability to speak, read, write, and understand English
Inability to provide written consent
Self-reported or known allergy to Afrin or Tetracaine HCL (or related class of drugs) and unable or willing to complete the laryngovideostroboscopy procedure with it.
Vocal Cord Atrophy Cohort:
Inclusion criteria:
Between 65 and 80 years of age
Clinical diagnosis of vocal cord atrophy (VCA)
Treated for the above condition by a provider at the Duke Head and Neck Surgery \& Communication Sciences Clinic
Elected to undergo voice therapy as standard of care for treatment of VCA
Exclusion criteria:
Other conditions that affect the voice and would interfere with study measures, as determined by PI
Inability to speak, read, write, and understand English
Inability to provide written consent
Self-reported or known allergy to Afrin or Tetracaine HCL (or related class of drugs) and unable or willing to complete the laryngovideostroboscopy procedure with it.

Where it is running

Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.